Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott COO Succession: Leiden Leaves, Gonzalez Takes Over Pharma Group

Executive Summary

Abbott Pharmaceutical Products Group President & COO Jeffrey Leiden's experience overseeing the Knoll acquisition could make the exec a particularly attractive candidate in the current climate of increasing M&A activity

You may also be interested in...



Abbott Gears Up For New Cholesterol Therapies, Winds Down Diagnostics

Building on two strategic initiatives announced last year - the acquisition of Kos and a collaboration with AstraZeneca - Abbott is gearing up to expand its commercial presence and late-stage pipeline in the cholesterol treatment market this year, President and Chief Operating Officer Richard Gonzalez said during the company's year-end sales and earnings call Jan. 24

Abbott Gears Up For New Cholesterol Therapies, Winds Down Diagnostics

Building on two strategic initiatives announced last year - the acquisition of Kos and a collaboration with AstraZeneca - Abbott is gearing up to expand its commercial presence and late-stage pipeline in the cholesterol treatment market this year, President and Chief Operating Officer Richard Gonzalez said during the company's year-end sales and earnings call Jan. 24

Bristol Interim CEO Pick Fuels Acquisition Rumors, Complicating Search

Bristol-Myers Squibb's search for a new CEO may be complicated by the widespread belief that the company is an acquisition target

Related Content

UsernamePublicRestriction

Register

ID1132090

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel